CM/PHR/23/5702 - NHS National Framework for Tocilizumab - March 2024
02182135
This tender has closed
The submission deadline for this contract has passed. There may be more active goods tenders from 02182135, and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
What happened
02182135 awarded this contract to Roche Products Ltd | Fresenius Kabi Limited worth £46,600,000 on 11 Mar 2024. The contract runs until 28 Feb 2025.
Description
Project Title: NHS National Framework for Tocilizumab - March 2024
Offer reference number: CM/PHR/23/5702
CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Awarded suppliers (2)
- Roche Products Ltd
- Fresenius Kabi Limited
Contact
Identifiers
Explore related tenders
External ID: cf-ocds-b5fd17-57b54e85-da9c-4332-bb93-8a7359735da5 • Added 3 October 2026